R. Oude Elferink

2.3k citations
13 papers · 1.8k indexed · 1 hit paper · h-index 7
Topics
Drug Transport and Resistance Mechanisms (6 papers)Neonatal Health and Biochemistry (3 papers)Liver Disease Diagnosis and Treatment (3 papers)
Partner nations
NetherlandsGermanyItaly

In The Last Decade

R. Oude Elferink

12 papers receiving 1.7k citations

Hit Papers

Mammalian ABC Transporters in Health and Disease200220262010201820024008001.2k

Peers

R. Oude Elferink
Comparison fields: 5 of 90
  • Oncology 1.3k
  • Molecular Biology 609
  • Pediatrics, Perinatology and Child Health 603
  • Surgery 404
  • Infectious Diseases 207
Replace Shin-ichi Akiyama with:
Shin-ichi Akiyama Japan
Manfred G. Ismair Switzerland
Daniel Rost Germany
R. Ottenhoff Netherlands
Kathleen Köck United States
G J Zaman Netherlands
M J Flens Netherlands
Satomi Tsukahara Japan
Diana Jung Switzerland
Jane E. Mackie Canada
R. Oude Elferink relative to Shin-ichi Akiyama Japan Shin-ichi Akiyama's profile →
Citations per field
00.5×1.5×
Shin-ichi Akiyama · 1×
Citations per year

Countries citing papers authored by R. Oude Elferink

Since Specialization
Citations

This map shows the geographic impact of R. Oude Elferink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Oude Elferink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Oude Elferink more than expected).

Fields of papers citing papers by R. Oude Elferink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Oude Elferink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Oude Elferink. The network helps show where R. Oude Elferink may publish in the future.

Co-authorship network of co-authors of R. Oude Elferink

This figure shows the co-authorship network connecting the top 25 collaborators of R. Oude Elferink. A scholar is included among the top collaborators of R. Oude Elferink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Oude Elferink. R. Oude Elferink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 1
5 1
6 18
7
Mutations in MDR3 in adult-onset cholangiopathy
2
8
Mammalian ABC Transporters in Health and Diseasebreakdown →
1222
9 14
10 35
11 417
12 53
13 32

About R. Oude Elferink

R. Oude Elferink is a scholar working on Clinical Biochemistry, Oncology and Hepatology, having authored 13 papers that have together received 1.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Neonatal Health and Biochemistry (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (1.3k citations), Pediatrics, Perinatology and Child Health (603 citations) and Pharmacology (163 citations). R. Oude Elferink has collaborated with scholars based in Netherlands, Germany and Italy. Frequent co-authors include Piet Borst, Piter J. Bosma, Rik J. Scheper, Marcel Kool, Frank ter Borg, Frank Baas, Coen C. Paulusma, George L. Scheffer, G. N. J. Tytgat and Erwin Schurr. Their work appears in journals such as Annual Review of Biochemistry, Gastroenterology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026